Concepedia

Nirasha Ramchurren

NR

23

Publications

2K

Citations

19

H-Index

1993

Active since

Affiliations

Fred Hutch Cancer Center(Current)

University of Washington

Stanford University

Bloomberg (United States)

Merck & Co., Inc., Rahway, NJ, USA (United States)

Nirasha Ramchurren is an author at Fred Hutch Cancer Center specializing in medicine, immunotherapy, and immunology.

ORCID

Top concepts

Publications per year

1993–2024

23

Publications

23

Durable Tumor Regression and Overall Survival in Patients With Advanced Merkel Cell Carcinoma Receiving Pembrolizumab as First-Line Therapy

Paul Nghiem, Shailender Bhatia, Evan J. Lipson et al. · Journal of Clinical Oncology · 2019 · 386 citations · Full text

Pembrolizumab in Relapsed and Refractory Mycosis Fungoides and Sézary Syndrome: A Multicenter Phase II Study

Michael S. Khodadoust, Alain H. Rook, Pierluigi Porcu et al. · Journal of Clinical Oncology · 2019 · 217 citations · Full text

Immune cell topography predicts response to PD-1 blockade in cutaneous T cell lymphoma

Darci J. Phillips, Magdalena Matusiak, Belén Rivero‐Gutiérrez et al. · Nature Communications · 2021 · 211 citations · Full text

Multidimensional, quantitative assessment of PD-1/PD-L1 expression in patients with Merkel cell carcinoma and association with response to pembrolizumab

Nicolás A. Giraldo, Peter Nguyen, Elizabeth L. Engle et al. · Journal for ImmunoTherapy of Cancer · 2018 · 179 citations · Full text

Three-year survival, correlates and salvage therapies in patients receiving first-line pembrolizumab for advanced Merkel cell carcinoma

Paul Nghiem, Shailender Bhatia, Evan J. Lipson et al. · Journal for ImmunoTherapy of Cancer · 2021 · 137 citations · Full text

Rows per page

1–5 of 23